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ABSTRACT 
Chronic sinusitis, defined as an inflammatory process that involves the paranasal sinuses and 
persists for 12 weeks or longer. The conventional treatment is either conservative or surgical. 
Since this ailment is of a chronic nature, simple conservative management will not be sufficient 
for a cure. Even though the surgery is effective, there is chance of recurrence and morbidity. 
The clinical picture of chronic sinusitis shows the predominance of Kaphavata dosha in 
Jatrurdhwa. Sigru is a single drug having Thikshna ushna guna and Vatakaphahara properties 
and is included in Sirovirechana group. Arkaprakasa written by Ravana illustrates a large 
number of Arkas (distillates) which is found to be very effective and harmless and Sigrubeeja 
Arka nasya indicated in Siroroga was selected for the study. 
Methods: The study design was interventional pre and post evaluation without control and 
sample size fixed as 30 patients. The data collection was done with case proforma, symptomatic 
scoring using VAS scale, Nasal Signs and Symptoms Score (NSSS), and X-ray PNS. Selected 
patients were subjected to Nasyakarma with Sigrubeeja arka for a period of 7 days. 
Assessments were done prior to the commencement of intervention and on 15th, 30th, 60th day 
of follow up. Statistical analysis was done using Wilcoxon Signed Rank test. 
Result: Change in outcome variables like headache, nasal obstruction, nasal discharge, loss of 
smell, and postnasal drip, showed significant results.  
Conclusion: Sigrubeejaarka was found to be effective in chronic sinusitis. 
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INTRODUCTION 
Chronic sinusitis is an inflammatory disease 
of the nasal and paranasal sinus mucosa. It is defined 
as chronic when it lasts longer than 3 months 
without complete symptom resolution. The literature 
has supported that chronic sinusitis is almost always 
accompanied by concurrent nasal airway 
inflammation and is often preceded by rhinitis 
symptoms; thus the term chronic rhinosinusitis 
(CRS) has evolved to more accurately describe the 
condition. 
 In modern science, treatment of CRS includes 
medical and surgical therapy. Medical therapy often 
requires combining multiple medications including 
antibiotics, nasal decongestants, topical nasal 
steroids and/or oral steroids, and saline irrigation. 
Some patients do not respond with full medical 
treatment alone; in these cases treatment with 
endoscopic sinus surgery should be considered as an 
alternative. Even though surgery is effective, there is 
a chance of recurrence and morbidity. The clinical 
picture of chronic sinusitis shows the predominance 
in the Kaphavata dosha. Nasya is one of the classical 
procedures among Panchakarma, which is ideal in 
Sirogata rogas. Sigru beeja has Teekshna ushna[1] 
property and is included in Sirovirechana group. 
Arkaprakasa written by Ravana illustrates a large 
number of Arkas (distillates) prepared using various 
parts of medicinal plants and Sigru beeja arka nasya 
is indicated in Siroroga.[2] Arka preparations are 
having potent action, long shelf life period, easy to 
manufacture, and patient friendly. Therefore 
Sigrubeeja arka nasya described in Arkaprakasa 
which is cost effective, affordable and easy to prepare 
with more benefits is selected for the study. 
Moreover the research works in Nasya with Arka 
preparation is found to be rare in the available 
literature. 
Objective  
To evaluate the effect of Sigrubeeja arka 
nasya in chronic sinusitis  
Study drug: Sigrubeeja arka 
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Methodology 
Study design: Therapeutic, Interventional, pre and 
post test design. 
Study setting 
OPD and IPD of department of Shalakya tantra, Govt 
Ayurveda College, Trivandrum. 
Study population  
Patients diagnosed as having chronic sinusitis, who 
are suitable for Nasya karma in the age group of 20-
50 yrs irrespective of sex. 
Inclusion criteria 
Patients diagnosed as having Chronic sinusitis age 
group between 20-50yrs of both sexes suitable for 
Nasya. 
Exclusion criteria 
 1. Congenital malformation of nostrils as congenital 
choanal atresia, nasal glioma 
 2. Diagnosed cases of TB on medication, malignant 
hypertension. 
 3. Patients with history of multiple episodes of 
epistaxis, disorders of blood coagulation traumatic 
injury of brain and diagnosed cases of cerebro 
vascular accidents. 
Sample size  
30 patients were selected 
Sampling technique 
Consecutive cases satisfying inclusion till attaining 
sample size. 
Data collection 
 Data were collected by personal interview 
method with the help of case proforma and clinical 
examination. 
Study tools 
 Clinical case proforma  
 Nasal signs and symptoms score for nasal 
obstruction[3] 
 Nasal signs and symptoms score for nasal 
discharge[4] 
 Nasal signs and symptoms score for loss of smell 
 Nasal signs and symptoms score for post nasal 
drip 
 X-ray paranasal sinuses 
Trial drug 
The study drug used was Sigru (Moringa 
pterygosperma) Beeja arka. 
Drug name: Sigru beeja 
Botanical name: Moringa pterygosperma  
Family: Moringaceae 
Preparation 
The medicine Sigrubeeja arka was prepared 
according to the procedure described in API.[5] 
Analytical Study of Sigrubeeja Arka 
Organoleptic Characters 
Colour: Transparent 
Odour: Smell of Sigrubeeja 
Touch: Cold 
Taste: As that of Sigrubeeja 
Consistency: Liquid 
Analytical Values 
Specific gravity: 1.0001 
Refractive index: 1.2 
Solid content: 0.12% 
Volatile oil content: 0.5% 
pH: 5.32 
Thin Layer Chromatography 
Result  
The TLC profile of ethyl acetate extract of the 
drug was done on pre-coated Silica gel 'G' plates. A 
good separation was produced with Chloroform: 
Toluene (3:2) as mobile phase. Under UV light 
(366nm) light blue fluorescent colour curve is 
detected with Rf. 0.75 (hrf 75) (blue). On exposure to 
Iodine vapour brown spot is observed with Rf 0.22 
(hrf 22). 
HPTLC (High Performance Thin Layer 
Chromatography) 
In UV scanning at 254nm and 366nm 
(Sigrubeeja arka) produced 4 peaks with Rf value 
0.06, 0.22, 0.40, and 0.65. Among these, peak 3rd and 
2nd showed maximum area of 44.22% (1461.1AU) 
and 29.22% (965.5AU) respectively.  
Clinical Study- Procedure 
After obtaining informed consent, the 
patients diagnosed as having chronic sinusitis and 
registered in OPD of Shalakya tantra, Govt. Ayurveda 
College Hospital, Trivandrum, were selected as per 
inclusion and exclusion criteria. Then they were 
subjected to Poorva karmas and Nasya karma was 
done as per the following schedule. 
Poorva karma 
The patients were advised to follow strict 
dietary control and life style practices during the 
treatment period as that described in the classics for 
Sodhana therapy. 
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Table 1: Poorvakarma of Nasya 
Treatment Medicine Dose Time Duration 
Sneha pana 
(Vicharana) 
Plain ghritha 10gm 8am and at 8pm along 
with food 
2 days 
Abyanga and sweda Tila tailam Quantity sufficient Morning 8 am 1 day 
Virechana Plain Eranda tailam 25ml with hot water 6 am in empty stomach 1 day 
Administration of Nasya 
As per classical Nasya procedure[6] 
Time: 8 am in empty stomach 
Dose: 4ml  
Duration of Nasya – 7 days 
Assessment 
1st assessment -Symptomatic evaluation was done before Nasya 
Follow up - 15th day, 30th day, and 60th day of Nasya 
Table 2: Outcome variable 
Symptoms Grade 0 Grade 1 Grade 2 Grade 3 
Headache Absent Mild  Moderate  severe 
Nasal obstruction Absent  Mild  Mouth breath  Interfere sleep 
Nasal discharge Absent Humid mucosa Visible discharge Profuse draining 
Loss of smell Absent Can’t smell mild 
odour 
Can’t smell 
moderate odour 
Can’t smell strong 
odour 
Post nasal drip Absent Feels secretion in 
throat 
Frequent 
clearing of throat 
Coughing/ 
affecting speech 
Radiology No haziness Mild hazy Moderate hazy  
X-ray PNS was taken before the study and in the follow up period (30th day) 
Statistical analysis 
Wilcoxon signed Rank test according to the type of distribution of the variable 
RESULT 
Most of the patients were females from rural areas. Majority of study patients had Vata kapha prakruthi with 
irregular food habits. 
Table 3: Distribution according to change in headache 
Headache Grade 0 Grade 1 Grade 2 Total 
N % N % N % 
BT 0 0 4 13.3 26 86.7 30 
AT 14 46.7 12 40 4 13.3 30 
AF1 11 36.7 16 53.3 3 10.0 30 
AF2 10 33.3 17 56.7 3 10.0 30 
(BT - before the commencement of treatment, AT – 15th day after Nasya, AF1 – 30th day after Nasya, AF2 
– 60th day of Nasya) 
Table 4: Analysis according to change in headache 
Paired comparison  
Wilcoxon signed rank test 
Z p 
BT-AT 4.617 <0.001 
BT-AF1 4.66 <0.001 
BT-AF2 4.562 <0.001 
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Graph No: 1 Distribution according to change in Nasal obstruction 
  
 
Table 5: Analysis on change in Nasal obstruction 
Paired comparison  
Wilcoxon signed rank test 
Z p 
BT-AT 4.796 <0.001 
BT-AF1 4.379 <0.001 
BT-AF2 4.491 <0.001 
Graph No 2: Distribution according to change in Nasal discharge 
 
Table 6: Analysis on change in Nasal discharge 
Paired comparison  
Wilcoxon signed rank test 
Z p 
BT-AT 4.123 <0.001 
BT-AF1 3.879 <0.001 
BT-AF2 4.001 <0.001 
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Graph No: 3 Distribution according to Change in loss of smell 
 
Table 7: Analysis on change in Loss of smell 
Paired comparison  
Wilcoxon signed rank test 
Z p 
BT-AT 4.413 <0.001 
BT-AF1 4.564 <0.001 
BT-AF2 4.456 <0.001 
Graph no 4: Distribution according to Change in Post nasal drip 
 
Table 8: Analysis on change in Post nasal drip 
Paired comparison  
Wilcoxon signed rank test 
Z p 
BT-AT 5.26 <0.001 
BT-AF1 5.035 <0.001 
BT-AF2 5.007 <0.001 
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Graph no 5: Distribution according to Change in Radiology 
  
Table 9: Analysis on Radiological change 
 Paired comparison 
Wilcoxon signed rank test 
Z p 
BT-AF1 5.099 <0.001 
DISCUSSION 
Discussion on Ayurvedic aspects of the Chronic 
sinusitis 
While analyzing the clinical features of 
chronic sinusitis we can’t correlate it to a single 
disease. The symptomatology reveals that it is a state 
of Kaphavata predominant condition in the Siras. 
Signs and symptoms of the Kaphaja sirasoola, 
Kaphaja pratisyaya and Dushta pratisyaya were 
enlisted and these were found to be similar with the 
clinical pictures of chronic sinusitis. As the disease is 
a chronic condition manifests as a result of untreated 
or improperly treated rhinitis, we can correlate it to 
Dushta pratisyaya which is a Yapya roga. In the 
Samprapthi of disease Pranamarga is obstructed due 
to Kapha dosha, and ultimate goal of the treatment is 
to relieve the Margarodha and thus clear the nasal 
pathway. So it is better to approach the disease as a 
Kaphavata predominant Urdwa Jatrugatavikara 
rather than a single disease. 
Discussion on probable mode of action of Drug  
Here in this disease Vata uparodha happens 
due to Kupitha kapha dosha. In Kapha 
avaranaavastha, Guru, Manda, Sthira and Sita guna of 
Kapha are dominant. It can be alleviated by drugs 
possessing Laghu, Tikshna guna and Ushna veerya. So 
the drug Sigru with Katu tiktha rasa, Laghu, Ushna, 
Teekshna guna[7] and Kaphavatahara property was 
selected for the study. The drug Sigru beeja is 
included in Sirovirechana gana and its Sodhana 
property helps in the Doshaharana from the 
Urdwanga.  
Discussion on the Nasya procedure 
 The provisions created by Purvakarma[8] 
helps in the Pradhana karma, where the drug 
administered remains momentary in nasal cavity and 
the position of head assisted by gravity helps in easy 
spreading of the medicine, so that the drug has a 
greater chance of adsorption in the air sinuses, as 
well as providing sufficient time for stimulating 
olfactory neurons. As explained earlier in the literary 
review; the Nasya karma acts on the Sringataka 
marma[9] which is a Sira marma present in the middle 
of the confluence of Siras supplying nourishment to 
the nose, ears, eyes and tongue.  
Nasya karma can stimulate the higher centers 
and regulate their function. Even though drug 
absorption may take place via vascular pathway, 
lymphatics, neurological pathway[10] and diffusion; 
more absorption occurs through vascular pathway 
due to rich blood supply of nasal mucosa. The pH of 
the drug also favours absorption. It may be due to 
this fact that, the formulation showed symptomatic 
relief as much absorption takes place in nasal mucosa 
and reduces the local inflammatory process  
CONCLUSION 
In Chronic sinusitis Vata avarana occurs due 
to Kupitha kapha dosha and can approach the disease 
as Kaphavata predominant Urdwa Jathrugatavikara. 
Sigrubeejaarka which is cost effective, affordable, 
more benefits and without complications was found 
to be effective in Chronic sinusitis. As the disease is 
chronic in nature repeated Sodhana therapy with 
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proper Pathyakrama should be incorporated to avoid 
the recurrence. 
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